Urine could play a key part in biotech systems


Tuesday, 22 November, 2022

Urine could play a key part in biotech systems

A common chemical found in urine can be used to kick-start large-scale production of proteins such as hormones and antibodies used by biotech companies, with researchers at the University of Birmingham and Aston University developing a system that uses urea to trigger the production of these proteins in the large quantities needed by the biotech industry.

Typically, in this process, small pieces of DNA are introduced into bacteria such as E. coli to persuade them to overproduce certain proteins. Overproduction, however, is typically triggered by ‘inducer’ molecules, which can be costly and often need careful handling, such as refrigeration. By using urea instead, the researchers have developed a method that is cheaper, more straightforward and uses easily accessible materials.

In a study, published in the journal New Biotechnology, the team investigated both purified urea and the urea contained in common garden fertilisers. They showed that similar results could be achieved using either source; study co-author Professor Steve Busby, from the University of Birmingham, said the aim was to make the technology “available to biotech companies who want to explore how to optimise their processes and also keep their costs down”.

The team also showed it was possible to fine-tune the amounts of protein triggered by the urea molecule, by varying the concentrations used. This is important to avoid harming or exhausting the host bacteria. They found it was possible to optimise production to quantities similar to those produced using medium-strength promoters currently used as standard by the biotech industry.

The study builds on earlier work in which the team successfully demonstrated that nitrate — a cheap, stable and abundant inorganic ion — could also be used as a trigger. Nitrate is commonly found in many commercial fertilisers and even in some garden fertilisers, meaning that it is always readily available, even in areas where other types of promoter chemicals might be inaccessible.

“Both urea and nitrate will be much more readily available, and easy to use, in locations where infrastructure limits access, for example where maintaining a cold supply chain is challenging,” said study co-author Dr Joanne Hothersall, also from the University of Birmingham. “We hope these new approaches will open up new avenues of research for biotech industries.”

Image credit: iStock.com/toeytoey2530

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Breast augmentation procedure uses 3D-printed scaffolds

3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...

Victoria detects H5N1 avian influenza strain

It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...

TGA acts on melatonin imports with infringement notices totalling $99K

Laboratory testing of several imported unregistered melatonin products has confirmed them to be...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd